I
12.49
-0.01 (-0.08%)
| Penutupan Terdahulu | 12.50 |
| Buka | 12.37 |
| Jumlah Dagangan | 878,993 |
| Purata Dagangan (3B) | 1,284,545 |
| Modal Pasaran | 1,569,780,608 |
| Harga / Jualan (P/S) | 1.44 |
| Harga / Buku (P/B) | 145.25 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 20 Feb 2025 - 24 Feb 2025 |
| Margin Keuntungan | -0.25% |
| Margin Operasi (TTM) | 30.62% |
| EPS Cair (TTM) | -0.030 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 13.30% |
| Nisbah Semasa (MRQ) | 0.830 |
| Aliran Tunai Operasi (OCF TTM) | -240.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -70.88 M |
| Pulangan Atas Aset (ROA TTM) | 11.27% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Indivior PLC | Menurun | - |
AISkor Stockmoo
1.5
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.50 |
|
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 3.75% |
| % Dimiliki oleh Institusi | 89.46% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Scopia Capital Management Lp | 30 Sep 2024 | 1,284,086 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 16.00 (Piper Sandler, 28.10%) | Beli |
| 16.00 (Craig-Hallum, 28.10%) | Beli | |
| Median | 16.00 (28.10%) | |
| Purata | 16.00 (28.10%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 8.23 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Piper Sandler | 25 Oct 2024 | 16.00 (28.10%) | Beli | 9.00 |
| 11 Oct 2024 | 15.00 (20.10%) | Beli | 7.46 | |
| Craig-Hallum | 11 Oct 2024 | 16.00 (28.10%) | Beli | 7.46 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |